论文信息 - Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study - 字舞流文

Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study

D. Murrell | V. Werth | R. Sinclair | S. Gourlay | A. Roussaki-Schulze | P. Joly | J. Kern | S. Baum | F. Caux | A. Neale | D. Thomas | I. Bassukas | P. Stavropoulos | A. Patsatsi | T. Zeeli | P. Arora